Nantahala Capital Management, LLC reported 110 positions worth $1.57B for the quarter ended Jun 30, 2026, up 5.9% on the prior quarter. It opened 14 new positions, added to 22, trimmed 37 and exited 17. Its largest holding is Bancorp, Inc. at 4.9% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Trade Value | Weight |
|---|---|---|---|
| ADMA Adma Biologics, Inc. | +2.36M | $19.75M | 1.26% |
| VOR Vor Biopharma Inc. | +845.0K | $15.56M | 0.989% |
| PLNT Planet Fitness, Inc. | +279.0K | $14.56M | 0.925% |
| INSP Inspire Medical Systems, Inc. | +269.5K | $12.02M | 0.764% |
| AVTX Avalo Therapeutics, Inc. | +627.3K +50.8% | $11.59M | 2.19% |
| IVA Inventiva S.A. | +2.69M | $10.15M | 0.646% |
| QURE uniQure N.V. | +218.6K +92.2% | $10.07M | 1.33% |
| FULC Fulcrum Therapeutics, Inc. | +2.43M +79.5% | $8.88M | 1.27% |
| CATX Perspective Therapeutics, Inc. | +2.33M | $7.93M | 0.504% |
| ADCT ADC Therapeutics SA | +6.73M +120.2% | $7.20M | 0.838% |
| Holding | Change | Trade Value | Weight |
|---|---|---|---|
| ESTA Establishment Labs Holdings Inc. | -497.1K -59.7% | $42.66M | 1.83% |
| PTON Peloton Interactive, Inc. | -6.89M -57.4% | $40.73M | 1.92% |
| HGV Hilton Grand Vacations Inc. | -480.5K -31.7% | $25.16M | 3.44% |
| TNGX Tango Therapeutics, Inc. | -749.8K -60.0% | $23.44M | 0.995% |
| AVR Anteris Technologies Global Corp. | -2.15M -38.8% | $21.15M | 2.12% |
| ZVRA Zevra Therapeutics, Inc. | -724.5K -28.7% | $10.39M | 1.64% |
| AMRX Amneal Pharmaceuticals, Inc. | -575.4K -20.2% | $9.96M | 2.5% |
| COGT Cogent Biosciences, Inc. | -250.0K -100.0% | $9.62M | Exited |
| SVC Service Properties Trust | -7.06M -100.0% | $9.56M | Exited |
| TBBK Bancorp, Inc. | -140.6K -10.2% | $8.81M | 4.94% |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| ADMA Adma Biologics, Inc. | +2.36M | $19.75M | 1.26% |
| VOR Vor Biopharma Inc. | +845.0K | $15.56M | 0.989% |
| PLNT Planet Fitness, Inc. | +279.0K | $14.56M | 0.925% |
| INSP Inspire Medical Systems, Inc. | +269.5K | $12.02M | 0.764% |
| IVA Inventiva S.A. | +2.69M | $10.15M | 0.646% |
| CATX Perspective Therapeutics, Inc. | +2.33M | $7.93M | 0.504% |
| TRAX First Tracks Biotherapeutics, Inc. | +250.0K | $5.03M | 0.32% |
| ALT Altimmune, Inc. | +1.50M | $4.56M | 0.29% |
| ZLAB Zai Lab Ltd | +200.0K | $3.80M | 0.242% |
| KLRA Kailera Therapeutics, Inc. | +140.0K | $3.08M | 0.196% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| COGT Cogent Biosciences, Inc. | -250.0K | $9.62M | 0.648% |
| SVC Service Properties Trust | -7.06M | $9.56M | 0.644% |
| SLDB Solid Biosciences Inc. | -1.17M | $8.39M | 0.565% |
| DNTH Dianthus Therapeutics, Inc. | -67.3K | $5.65M | 0.38% |
| KOS Kosmos Energy Ltd. | -1.84M | $5.13M | 0.345% |
| RVMD Revolution Medicines, Inc. | -50.0K | $4.86M | 0.327% |
| CZR Caesars Entertainment, Inc. | -150.0K | $3.96M | 0.267% |
| UPB Upstream Bio, Inc. | -400.0K | $3.60M | 0.242% |
| NNBR Nn Inc | -2.44M | $3.54M | 0.238% |
| GRCE Grace Therapeutics, Inc. | -728.2K | $3.37M | 0.227% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | TBBK Bancorp, Inc. | Financial Services | 1.24M | $77.67M | 4.94% | -140.6K | -10.2% | Reduced | 2.99% |
| 2 | BVS Bioventus Inc. | Healthcare | 6.00M | $56.64M | 3.6% | -122.1K | -2.0% | Reduced | 8.8% |
| 3 | HGV Hilton Grand Vacations Inc. | Consumer Discretionary | 1.03M | $54.11M | 3.44% | -480.5K | -31.7% | Reduced | 1.3% |
| 4 | SVRA Savara Inc | Healthcare | 6.98M | $42.98M | 2.73% | -368.0K | -5.0% | Reduced | 2.75% |
| 5 | ETON Eton Pharmaceuticals, Inc. | Healthcare | 1.18M | $42.57M | 2.71% | 0 | 0.0% | Unchanged | 4.16% |
| 6 | AMRX Amneal Pharmaceuticals, Inc. | Healthcare | 2.27M | $39.27M | 2.5% | -575.4K | -20.2% | Reduced | 0.71% |
| 7 | EOLS Evolus, Inc. | Healthcare | 5.60M | $38.88M | 2.47% | -774.8K | -12.2% | Reduced | 8.49% |
| 8 | AVTX Avalo Therapeutics, Inc. | Healthcare | 1.86M | $34.41M | 2.19% | +627.3K | +50.8% | Added | 3.52% |
| 9 | LBRX Lb Pharmaceuticals Inc | Healthcare | 1.05M | $34.17M | 2.17% | 0 | 0.0% | Unchanged | 3.49% |
| 10 | AVR Anteris Technologies Global Corp. | Healthcare | 3.38M | $33.33M | 2.12% | -2.15M | -38.8% | Reduced | 3.47% |
| 11 | ABEO Abeona Therapeutics Inc. | Healthcare | 5.14M | $31.74M | 2.02% | +123.4K | +2.5% | Added | 8.98% |
| 12 | PTON Peloton Interactive, Inc. | Consumer Discretionary | 5.11M | $30.19M | 1.92% | -6.89M | -57.4% | Reduced | 1.16% |
| 13 | ESTA Establishment Labs Holdings Inc. | Healthcare | 335.8K | $28.82M | 1.83% | -497.1K | -59.7% | Reduced | 1.11% |
| 14 | XTNT Xtant Medical Holdings, Inc. | Healthcare | 68.39M | $28.79M | 1.83% | 0 | 0.0% | Unchanged | 48.76% |
| 15 | JACK Jack In The Box Inc | Consumer Discretionary | 1.73M | $27.33M | 1.74% | +185.9K | +12.1% | Added | 2.08% |
Tip. Select a row to see that position’s full history at Nantahala Capital Management.
As of its Q2 2026 13F filing, Nantahala Capital Management, LLC’s five largest positions were Bancorp, Inc. (TBBK) at 4.9%, Bioventus Inc. (BVS) at 3.6%, Hilton Grand Vacations Inc. (HGV) at 3.4%, Savara Inc (SVRA) at 2.7%, Eton Pharmaceuticals, Inc. (ETON) at 2.7% of the reported portfolio.
Nantahala Capital Management, LLC reported a 13F portfolio worth $1.57B across 110 positions for Q2 2026. That is up 5.9% from the previous quarter.
Its largest purchases by value were Adma Biologics, Inc. ($19.75M), Vor Biopharma Inc. ($15.56M), Planet Fitness, Inc. ($14.56M). It opened 14 new positions.
Its largest sales by value were Establishment Labs Holdings Inc. ($42.66M), Peloton Interactive, Inc. ($40.73M), Hilton Grand Vacations Inc. ($25.16M). It exited 17 positions entirely.
From the Form 13F-HR reports Nantahala Capital Management, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.